scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1471-4159.1998.71020790.X |
P698 | PubMed publication ID | 9681471 |
P2093 | author name string | Meana JJ | |
Pineda J | |||
Mateo Y | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | norepinephrine | Q186242 |
P304 | page(s) | 790-798 | |
P577 | publication date | 1998-08-01 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine | |
P478 | volume | 71 |
Q28345792 | Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study |
Q30559226 | Alpha2A- but not alpha2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data |
Q46923731 | Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat. |
Q37422439 | Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality |
Q30445190 | Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons |
Q45270552 | Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. |
Q42473400 | Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus |
Q28345858 | Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex |
Q35869960 | Desipramine selectively potentiates norepinephrine-elicited ERK1/2 activation through the α2A adrenergic receptor |
Q48105287 | Determination of the somatodendritic alpha2-adrenoceptor subtype located in rat locus coeruleus that modulates cortical noradrenaline release in vivo |
Q35024537 | Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience |
Q47946543 | Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study. |
Q47628592 | Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats |
Q35045894 | Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice |
Q37371545 | Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). |
Q36726610 | Heterotrimeric g proteins: insights into the neurobiology of mood disorders. |
Q73515525 | Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus |
Q58611880 | Iatrogenic hypertension: a bioinformatic analysis |
Q34133350 | In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2)-adrenoceptors. |
Q62082733 | Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo |
Q74063339 | Intraventricular insulin suppresses the acoustic startle response in rats |
Q45242499 | Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain |
Q42686822 | Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible? |
Q42477825 | Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade. |
Q35041626 | Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. |
Q44112148 | Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. |
Q46220981 | Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration |
Q35807313 | Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus. |
Q40781164 | Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome. |
Q52298415 | Repeated immobilization stress increases nur77 expression in the bed nucleus of the stria terminalis. |
Q48093265 | Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. |
Q34117810 | Serotonin releasing agents. Neurochemical, therapeutic and adverse effects |
Q81318997 | Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release |
Q35041707 | Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain |
Q47235560 | The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers |
Q35371943 | The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo. |
Q33772703 | The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias |
Q43656819 | The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis |
Q34142899 | Therapeutic and adverse actions of serotonin transporter substrates |
Q34295208 | α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy |
Search more.